Northwire Canada EditionFriday, July 10, 2026
Northwire
S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0% S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0%
Financings

Hapbee Announces R&D of Three New Frequency Wellness Signals for Hunger Management, Allergy Comfort, and Sexual Vitality; Closes Private Placement and Appoints Director

HAPB · Price

Executive Summary

  • Hapbee Technologies announced the development of three new frequency‑wellness signals—Hunger Management, Allergy Comfort and Sexual Vitality—currently in R&D and internal testing, with pilot experiences slated for later 2025.
  • The company closed a non‑brokered private placement issuing 7,425,000 units at CAD 0.10 per unit, raising gross proceeds of CAD 742,500 to fund product development, working capital and general corporate purposes.
  • Krishna Subramanian was appointed to the board of directors as Chief Financial Officer.

Key Details

  • New Wellness Signals (R&D):
  • Hunger Management: Aims to help users align with natural hunger rhythms for mindful eating.
  • Allergy Comfort: Intended to promote ease during seasonal or environmental changes.
  • Sexual Vitality: Designed to support confidence, energy and intimacy through uplifting frequency patterns.
  • All three signals are in the R&D/internal testing phase; pilot experiences expected later in 2025 via Hapbee’s consumer wellness platform.

  • Private Placement Closing:

  • Total units issued: 7,425,000 (each unit = 1 subordinate voting common share + 1 non‑transferable warrant).
  • Issue price: CAD 0.10 per unitgross proceeds of CAD 742,500.
  • Warrant terms: exercisable for one additional share at CAD 0.15 per share for three years; accelerated expiry possible if TSX‑V share price > CAD 0.30 for ten consecutive trading days after the hold period (Feb 21 2025).
  • Hold period: four months and one day, expiring Feb 21 2025.
  • Use of proceeds: fund product and business development, working capital, and general corporate purposes. No finder’s fees paid; no related‑party participation.

  • Board Appointment:

  • Krishna Subramanian appointed to the board of directors as Chief Financial Officer (announced previously on Sep 12 2025).

Notable Quotes

“Our mission is to make people feel good, safely and naturally, on demand and at your control,” said Riz Shah, Chairman of Hapbee.
“These new signals build on Hapbee’s mission to pioneer frequency wellness for modern living — empowering people to take control of their wellbeing without medicine, just resonance.”

Read the original news release →

More from Hapbee Technologies, Inc.